Modern chemotherapeutic regimens in the management of aggressive non-Hodgkin lymphoma: Can they be improved?
- 31 December 1991
- journal article
- review article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27 (4), 510-513
- https://doi.org/10.1016/0277-5379(91)90398-w
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Expression of mdr1 and mdr3 Multidrug-resistance Genes in Human Acute and Chronic Leukemias and Association With Stimulation of Drug Accumulation by CyclosporineJNCI Journal of the National Cancer Institute, 1990
- Resistance to methotrexate and multidrug resistance in childhood malignanciesAdvances in Enzyme Regulation, 1989
- Prognostic implications of cell kinetics, histopathology and pathologic stage in non‐Hodgkin's lymphomasHematological Oncology, 1989
- Prediction of Doxorubicin Resistance In Vitro in Myeloma, Lymphoma, and Breast Cancer by P-Glycoprotein StainingJNCI Journal of the National Cancer Institute, 1989
- Correlation of morphology, immunophenotype, and flow cytometry with remission induction and survival in high grade non-Hodgkin's lymphomaThe Journal of Pathology, 1989
- Flow cytometric DNA analysis: A prognostic tool in non-hodgkin's lymphomaLeukemia Research, 1989
- Proliferative rates of non-Hodgkin's lymphomas as assessed by Ki-67 antibodyHuman Pathology, 1987
- High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's LymphomaNew England Journal of Medicine, 1987
- Identification of Major Prognostic Subgroups of Patients with Large-Cell Lymphoma Treated with m-BACOD or M-BACODAnnals of Internal Medicine, 1986
- MACOP-B Chemotherapy for the Treatment of Diffuse Large-Cell LymphomaAnnals of Internal Medicine, 1985